DE68916424D1 - Pasteurella-impfstoff. - Google Patents
Pasteurella-impfstoff.Info
- Publication number
- DE68916424D1 DE68916424D1 DE68916424T DE68916424T DE68916424D1 DE 68916424 D1 DE68916424 D1 DE 68916424D1 DE 68916424 T DE68916424 T DE 68916424T DE 68916424 T DE68916424 T DE 68916424T DE 68916424 D1 DE68916424 D1 DE 68916424D1
- Authority
- DE
- Germany
- Prior art keywords
- toxin
- analog
- detoxified
- pasteurella multocida
- vaccine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 229960005486 vaccine Drugs 0.000 title abstract 3
- 241000606860 Pasteurella Species 0.000 title 1
- 239000003053 toxin Substances 0.000 abstract 14
- 231100000765 toxin Toxicity 0.000 abstract 14
- 108010059749 Pasteurella multocida toxin Proteins 0.000 abstract 3
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 2
- 239000013604 expression vector Substances 0.000 abstract 2
- 244000005700 microbiome Species 0.000 abstract 2
- 239000002773 nucleotide Substances 0.000 abstract 2
- 125000003729 nucleotide group Chemical group 0.000 abstract 2
- 241001465754 Metazoa Species 0.000 abstract 1
- 229940039227 diagnostic agent Drugs 0.000 abstract 1
- 239000000032 diagnostic agent Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000003053 immunization Effects 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 238000003780 insertion Methods 0.000 abstract 1
- 230000037431 insertion Effects 0.000 abstract 1
- 238000012986 modification Methods 0.000 abstract 1
- 230000004048 modification Effects 0.000 abstract 1
- 230000000010 osteolytic effect Effects 0.000 abstract 1
- 230000001124 posttranscriptional effect Effects 0.000 abstract 1
- 230000003362 replicative effect Effects 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- C07K16/1242—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/832—Drug, bio-affecting and body treating compositions involving bacterial toxin that has modified amino acid sequence
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Urology & Nephrology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Gastroenterology & Hepatology (AREA)
- Cell Biology (AREA)
- Pulmonology (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK199588A DK199588D0 (da) | 1988-04-12 | 1988-04-12 | Vaccine |
| PCT/DK1989/000084 WO1989009617A1 (en) | 1988-04-12 | 1989-04-11 | A pasteurella vaccine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE68916424D1 true DE68916424D1 (de) | 1994-07-28 |
| DE68916424T2 DE68916424T2 (de) | 1994-11-10 |
Family
ID=8109323
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE68916424T Expired - Lifetime DE68916424T2 (de) | 1988-04-12 | 1989-04-11 | Pasteurella-impfstoff. |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US5369019A (de) |
| EP (1) | EP0409895B1 (de) |
| AT (1) | ATE107516T1 (de) |
| AU (1) | AU3532089A (de) |
| DE (1) | DE68916424T2 (de) |
| DK (1) | DK199588D0 (de) |
| IE (1) | IE64033B1 (de) |
| WO (1) | WO1989009617A1 (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK199588D0 (da) * | 1988-04-12 | 1988-04-12 | Nordisk Droge & Kemikalie | Vaccine |
| ES2136064T3 (es) * | 1990-06-13 | 1999-11-16 | Pfizer | Vacunas de toxoide de pasteurella multocida. |
| DK120792D0 (da) * | 1992-09-30 | 1992-09-30 | Bioteknologisk Inst | Protein |
| EP0668779A4 (de) * | 1992-11-06 | 1996-08-21 | Univ Minnesota | Impstoff zum Shutz gegen Pasteurellose - Infektion durch P.multocida. |
| GB0204387D0 (en) * | 2002-02-26 | 2002-04-10 | Secr Defence | Screening process |
| JP2008502605A (ja) * | 2004-06-16 | 2008-01-31 | スマート ドラッグ システムズ インコーポレイティド | 徐放性ワクチン組成物 |
| TWI285647B (en) * | 2004-08-20 | 2007-08-21 | Univ Nat Chunghsing | Prevention, treatment and detection of porcine progressive atrophic rhinitis |
| CN101496899B (zh) * | 2004-08-20 | 2011-08-24 | 简茂盛 | 猪进行性萎缩性鼻炎的预防、治疗与检测 |
| CN1736479A (zh) | 2004-08-20 | 2006-02-22 | 简茂盛 | 猪进行性萎缩性鼻炎的预防、治疗与检测 |
| KR101699245B1 (ko) * | 2015-12-21 | 2017-02-13 | 주식회사 인트론바이오테크놀로지 | 신규한 파스튜렐라 멀토시다 박테리오파지 Ｐａｓ-ＭＵＰ-1 및 이의 파스튜렐라 멀토시다 균 증식 억제 용도 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4293545A (en) * | 1980-03-31 | 1981-10-06 | Norden Laboratories, Inc. | Modified Pasteurella multocida bacteria vaccines |
| NL8200392A (nl) * | 1982-02-03 | 1983-09-01 | Duphar Int Res | Werkwijze ter bereiding van een immunogeen van pasteurella multocida. |
| SE8205892D0 (sv) * | 1982-10-18 | 1982-10-18 | Bror Morein | Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin |
| US4677070A (en) * | 1985-04-26 | 1987-06-30 | Cetus Corporation | Pseudomonas aeruginosa exotoxin A antibodies, their preparation and use |
| DK199588D0 (da) * | 1988-04-12 | 1988-04-12 | Nordisk Droge & Kemikalie | Vaccine |
-
1988
- 1988-04-12 DK DK199588A patent/DK199588D0/da not_active Application Discontinuation
-
1989
- 1989-04-11 AU AU35320/89A patent/AU3532089A/en not_active Abandoned
- 1989-04-11 US US07/582,945 patent/US5369019A/en not_active Expired - Lifetime
- 1989-04-11 EP EP89905073A patent/EP0409895B1/de not_active Expired - Lifetime
- 1989-04-11 IE IE115189A patent/IE64033B1/en not_active IP Right Cessation
- 1989-04-11 WO PCT/DK1989/000084 patent/WO1989009617A1/en active IP Right Grant
- 1989-04-11 AT AT89905073T patent/ATE107516T1/de not_active IP Right Cessation
- 1989-04-11 DE DE68916424T patent/DE68916424T2/de not_active Expired - Lifetime
-
1994
- 1994-08-22 US US08/293,314 patent/US6110470A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US6110470A (en) | 2000-08-29 |
| WO1989009617A1 (en) | 1989-10-19 |
| DK199588D0 (da) | 1988-04-12 |
| ATE107516T1 (de) | 1994-07-15 |
| US5369019A (en) | 1994-11-29 |
| IE891151L (en) | 1989-10-12 |
| DE68916424T2 (de) | 1994-11-10 |
| IE64033B1 (en) | 1995-06-28 |
| EP0409895B1 (de) | 1994-06-22 |
| EP0409895A1 (de) | 1991-01-30 |
| AU3532089A (en) | 1989-11-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI883876A (fi) | Menetelmä rokotteen valmistamiseksi streptokokki-infektioita vastaan | |
| DE69127440D1 (de) | Lebende vakzine | |
| EP0793717A4 (de) | Orale immunisierung durch verwendung von transgenen pflanzen | |
| ATE359370T1 (de) | Heterologe antigene in stämmen zur impfung mit lebendzellen | |
| ATE127345T1 (de) | Stressproteine und verwendungen dafür. | |
| FI101632B1 (fi) | Menetelmä Bordetella pertussis-toksiinin alayksikön analogien valmistamiseksi ja niitä koodaavia rekombinantti-DNA-molekyylejä | |
| ATE107516T1 (de) | Pasteurella-impfstoff. | |
| DK341679A (da) | Vaccine mod streptokokker og fremgangsmaade til fremstilling deraf | |
| ATE149569T1 (de) | Verfahren zur herstellung von impfstoffen oder toxoiden | |
| GB1492596A (en) | Tetanus toxoid and process for its manufacture | |
| IE810618L (en) | Pasteurella vaccines | |
| AU601415B2 (en) | A process for the purification, solubilization and/or detoxification of protein antigens of bacteria of the bordetella genus using a carbonate buffer and an acellular anti-whooping cough vaccine | |
| SE8205247D0 (sv) | Fiskvacciner | |
| DK230890A (da) | Dna-fragment, der koder for et pasteurella multocida-toxin eller for en subsekvens eller analog deraf, ekspressionsvektor, der omfatter dna-fragmentet, mikroorganisme, der udtrykker dette, fremgangsmaade til fremstilling af et pasteurella-multocida-toxin, diagnostisk middel samt anvendelse heraf, vaccine indeholdende et pasteurella-multocida-toxinderivat, anvendelse af pasteurella multocida-t m.m. | |
| KR890000106A (ko) | 원생성 기생충 예방용 백신 | |
| ATE159758T1 (de) | Azelluläre impfstoffe |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |